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N-methyl-D-aspartate receptors (NMDARs) in all hippocampal areas play an essential
role in distinct processes of memory formation as well as in sustaining cell survival
of postnatally generated neurons in the dentate gyrus (DG). In contrast to the
beneficial effects, over-activation of NMDARs has been implicated in many acute and
chronic neurological diseases, reason why therapeutic approaches and clinical trials
involving receptor blockade have been envisaged for decades. Here we employed
genetically engineered mice to study the long-term effect of NMDAR ablation on
selective hippocampal neuronal populations. Ablation of either GluN1 or GluN2B causes
degeneration of the DG. The neuronal demise affects mature neurons specifically in
the dorsal DG and is NMDAR subunit-dependent. Most importantly, the degenerative
process exacerbates with increasing age of the animals. These results lead us to
conclude that mature granule cells in the dorsal DG undergo neurodegeneration
following NMDAR ablation in aged mouse. Thus, caution needs to be exerted when
considering long-term administration of NMDAR antagonists for therapeutic purposes.
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INTRODUCTION
The dentate gyrus (DG) in the hippocampus has been the focus of numerous studies for
two main reasons. Firstly, the DG is a major station in the trisynaptic pathway that conveys
input from the cortex to the hippocampus. DG granule cells excite CA3 neurons, which in
turn project to CA1 neurons. All hippocampal subregions have been much investigated in
the context of distinct forms of plasticity, learning, and memory (e.g., McHugh et al., 2007;
Niewoehner et al., 2007; Gu et al., 2012; Nakashiba et al., 2012). Secondly, the DG is one of
the two principal neurogenic niches in the postnatal brain, and has been therefore frequently
studied in the context of neurogenesis (reviewed in Jessberger and Gage, 2014). Some studies
addressed questions that link these two research areas. Thus, young DG granule cells support
pattern separation, whereas mature granule cells facilitate pattern completion (Nakashiba et al.,
2012). The DG comprises a dorsal and a ventral part that can be distinguished on anatomical
grounds, and also based on distinct functions that the two areas support. Thus, the dorsal
DG is involved in cognitive functions such as spatial memory, whilst the ventral DG supports
brain functions related to stress, emotion, and aﬀect (reviewed in Fanselow and Dong, 2010).
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Several decades of pharmacological and genetic research have
taught us that N-methyl-D-aspartate receptors (NMDARs) are
intricately linked to hippocampus-dependent memory (reviewed
in Bannerman et al., 2014). Mouse genetics was fundamental to
correlate subregions of the hippocampus, including the DG, with
distinct functions supporting spatial memory (McHugh et al.,
2007; Niewoehner et al., 2007). Thus, NMDARs in the DG are
required for pattern separation (McHugh et al., 2007) and spatial
working memory (Niewoehner et al., 2007). Furthermore, studies
based on mouse mutants were instrumental in helping delineate
the diﬀerential functions of NMDAR subunits. DG granule cells,
like most neurons in the hippocampus, harbor NMDARs built
from the obligatory GluN1 subunit (encoded by Grin1) and
the developmentally regulated GluN2A and GluN2B subunits
(encoded by Grin2a and Grin2b, respectively; Monyer et al.,
1994; Rodenas-Ruano et al., 2012; Paoletti et al., 2013). NMDARs
have been much discussed with respect to their function in
postnatal neurogenesis. Thus, NMDARs in postnatally generated
DG granule cells are a prerequisite for the survival of newborn
neurons (Tashiro et al., 2006).
In mature neurons, over-activation or suppression of
NMDARs are detrimental for cell function and survival.
Thus, enhanced receptor activity as it occurs in many
pathophysiological neurological diseases, e.g., stroke, epilepsy,
induces excitotoxic cell death (reviewed in Choi, 1992; Paoletti
et al., 2013). Conversely, pharmacological blockade of NMDARs
for hours and days also has an adverse eﬀect, as it induces cellular
vacuolization in pyramidal neurons in many cortical brain areas
(e.g., Ikonomidou et al., 1999). The eﬀect of prolonged or even
permanent NMDAR blockade on the survival of mature neurons
has not yet been tested systematically. Moreover, a potential
role of NMDARs for cell survival in aged animals has not been
investigated. This is surprising, given that the NMDAR has been
a key candidate when considering therapeutic strategies for
stroke.
Here we took advantage of genetically modiﬁed mice and
addressed the question whether the survival of mature and aged
neurons depends on NMDARs. We demonstrate that in the
hippocampus, mature neurons in the DG, but not in the CA1
region, require intact NMDAR function for survival.
MATERIALS AND METHODS
Animals
Animals were housed and handled according to the respected
animal welfare guidelines and rules of the Max Planck Society
and the Germany government animal welfare oﬃce in Karlsruhe,
Germany. The following genetically modiﬁed male and female
C57Bl/6N mice were used in this study: DG and CA1 selective
Grin1 knockout (Grin1DGCA1) mice (Bannerman et al., 2012),
DG selective Grin1 knockout (Grin1DG, previously called
NR1DG) mice (Niewoehner et al., 2007), Grin2a knockout
(Grin2a−/−, previously called homozygousGluRε1mutant) mice
(Sakimura et al., 1995), and DG and CA1 selective Grin2b
knockout (Grin2bDGCA1, previously called NR2B HPC) mice
(von Engelhardt et al., 2008).
Grin1DGCA1 mice are homozygous for the ﬂoxed Grin1
and carry two transgenes, TgLC1 and TgCN12, which enable
doxycycline-sensitive, Cre-mediated gene ablation in CA1 and
DG excitatory neurons and piriform cortex in the adult brain
by use of a CamKIIa/Grin2c hybrid promoter (Bannerman
et al., 2012). Grin1DG mice are homozygous for Grin1 and
carry the transgenes TgLC1 and TgCN10−itTA, which are the
same transgenes as in TgCN12, but yield diﬀerential expression
in the two transgenic mouse lines. In Grin1DG mice, Cre
is speciﬁcally expressed in the DG granule cells and some
CA1 pyramidal neurons (Niewoehner et al., 2007) which
express calbindin (CB; data not shown). Grin2bDGCA1 mice
are homozygous for the ﬂoxed Grin2b and carry TgLC1 and
TgCN12. For the selective expression of Cre in Grin1DGCA1,
Grin1DG and Grin2bDGCA1 mice, doxycycline was given
via the drinking water to pregnant mice to suppress Cre
expression of the oﬀspring during embryonic development, and
was withdrawn after birth (Bannerman et al., 2012). Doxycycline
treatment was performed under the license 35-9185.81/G71/10
of the governmental council in the Karlsruhe, Germany. In
Grin1DGCA1 mice, Cre expression becomes detectable as early
as postnatal day P28 (Bannerman et al., 2012). Control mice (i.e.,
mice with no Cre expression) to be compared with Grin1DGCA1
and Grin1DG mice were homozygous for ﬂoxed Grin1 and
carried one or none of the transgenes. Control mice for the
Grin2a knockout mice are wild-type mice. Control mice for
Grin2bDGCA1 mice were homozygous for ﬂoxed Grin2b and
carried one or none of the transgene. As control mice for
Cre expressing mice (carrying only TgLC1 and TgCN12 but
no ﬂoxed gene) we used either wild-type mice or carriers
of one of the transgenes. Following mice are available at
EMMA (https://www.infrafrontier.eu) with respective EMMA
ID: Floxed Grin1 mice (EM: 09220), mice carrying TgLC1 and
TgCN12 transgenes (EM: 09256), and mice carrying TgCN10−itTA
transgene (EM: 09255). All animal experiments were performed
according to the regulations of Heidelberg University/German
Cancer Research Center/Max Planck Institute.
Immunohistochemistry
Mice were perfused with phosphate buﬀered saline (PBS,
pH 7.4) followed by 4% paraformaldehyde (PFA). Brains
were removed and postﬁxed with 2% PFA at 4◦C overnight.
Coronal sections were prepared at 50 μm using a vibratome.
Sections were blocked and permeabilized with 5% bovine
serum albumin (BSA) in PBS containing 0.5% Triton X-100,
incubated with primary antibodies overnight at 4◦C, then
incubated with appropriate secondary antibodies. Primary and
secondary antibodies were diluted in PBS containing 0.2% Triton
X-100 before incubation. Sections were washed three times
with PBS after every antibody incubation step. Sections were
counterstained with DAPI (Invitrogen, Carlsbad, CA, USA) after
the secondary antibody incubation step. For GluN1 staining,
before blocking the sections, antigen retrieval was performed
as follows. Sections were immersed in 10 mM sodium citrate
(pH 6.0) and heated in a microwave oven for 5 min at 650 W
twice with a 5 min break in between, kept for 20 min at
room temperature, and washed twice with PBS. The following
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primary antibodies were used: rabbit active caspase-3 (catalog
# AF835; 1:2000; polyclonal; R&D systems, Minneapolis, MN,
USA), mouse CB D-28k (300; 1:2000; monoclonal; Swant,
Switzerland), goat DCX (sc-8066; 1:500; polyclonal; Santa Cruz
Biotechnology, Santa Cruz, CA, USA), goat Sox-2 (sc-17320;
1:500; polyclonal; Santa Cruz Biotechnology), mouse GFAP
(G3893; 1:10000; monoclonal; Sigma–Aldrich, Saint Louis, MO,
USA), rabbit S100β (721; 1:2000; polyclonal; Swant), rabbit
NMDAR1 (for GluN1; AB9864R; 1:250, monoclonal; Millipore,
Billerica, MA, USA), rabbit Cre [1:2000; polyclonal; a generous
gift from Dr. Günther Schütz (Kellendonk et al., 1999)], mouse
Mineralocorticoid receptor [6G1; 1:100; monoclonal; a generous
gift from Dr. Elise P. Gomez-Sanchez (Gomez-Sanchez et al.,
2006)].
Nissl Staining
Sections were mounted onmicroscope slides, air dried, immersed
in 0.1% thionin, washed with water, dehydrated in 70, 95,
and 100% ethanol for several minutes, cleared in xylene for
5 min twice. The slides were subsequently covered with Eukitt
mounting medium, and mounted with coverslips.
Image Processing and Quantification
Fluorescent images were acquired using a LSM 700 confocal
microscope (Zeiss, Oberkochen, Germany). A single focal plane
picture of the whole DG area from one hemisphere was
taken from each brain section using a tile scan function of
the confocal microscope. Bright ﬁeld images were acquired
using a BX51W microscope (Olympus, Tokyo, Japan). All
quantiﬁcation analyses were done using ImageJ software. The DG
thickness was measured from both dorsal/suprapyramidal blade
and ventral/infrapyramidal blade. Care was taken to minimize
variations in choosing sections in the rostrocaudal axis. Several,
typically three, DG images from one animal were used for the
analysis whenever possible. Measured values were averaged to
create one representative value for each animal. To calculate DG
thickness, a part of the DG with uniform thickness was selected
as rectangular area of interest, and the area was then divided by
the base length of the rectangular area. Dorsal DG thickness was
calculated from the proximal areas to the crest where the two
blades connect. Ventral DG thickness was calculated from the
most ventral area close to the end of the blade. Degenerating
cells were counted using the green channel after staining with
antibody against active caspase-3. A cell was considered DCX-
positive when the signal outlined the shape of a cell body
with processes. To conﬁrm that active capsase-3 (stained in
green ﬂuorescence) is expressed in CB-positive (stained in red
ﬂuorescence) cells, images of active caspase-3 positive cells
were taken when there was no auto-ﬂuorescence signal from
degenerating cells in an unstained (far-red ﬂuorescence) channel.
Degenerating cells were counted as follows. The DG area to be
examined was selected with selection tools. Putative degenerating
cells were selected by MaxEntropy method of the autothreshold
function, and signals bigger than 3 μm2 were counted using
“Analyze particles” function. We conﬁrmed that this counting
method matches manual counting. This method enabled us
to quantify degenerating cells more objectively than manual
counting. Except for degenerating cells, all other ﬂuorescently
labeled cells were counted manually using cell counter function
of ImageJ. Three to six images of the DG were used for counting
ﬂuorescent positive cells, and the obtained values were pooled to
obtain one value for each mouse.
Statistical Analysis
Quantiﬁcations were carried out without referring to the
genotype information. Diﬀerences or correlations between
groups were examined using the statistical tests indicated in
the ﬁgure legends. Statistical analyses were performed using R
3.1.3. Values were expressed as mean± standard deviation unless
otherwise mentioned in the ﬁgure legends. Values of p < 0.05
were considered statically signiﬁcant (∗p < 0.05, ∗∗p < 0.005,
∗∗∗p < 0.0005).
RESULTS
GluN1 Ablation Causes Progressive
Degeneration of Granule Cells in the
Dorsal DG
In 6 months old Grin1DGCA1 mice, in which Grin1 is deleted
in both the DG and CA1, we found a reduced thickness of
the DG granule cell layer (Figures 1A,B,H). This phenotype
could be readily detected by eye after DAPI staining, and was
more pronounced in 18 months old mice (Figures 1C,D,H).
In contrast, there was no apparent abnormality in the CA1
region in 18 months old Grin1DGCA1 mice (Figures 1E,F,I).
Expression of active caspase-3 in CB-positive granule cells was
indicative of mature granule cell demise (Figure 1G). The
alteration in the granule cell layer was restricted to the dorsal
DG. In 18 months old mice, the ventral DG in Grin1DGCA1
mice was comparable to that of controls (Supplementary Figures
S1A–C). We conﬁrmed GluN1 ablation in the CA1 region
and in both the dorsal and ventral DG of 6 months old
Grin1DGCA1 mice by immunohistochemistry (Supplementary
Figures S1D–G). Neuronal degeneration did not result from Cre
expression itself, but was a consequence ofGrin1 deletion via Cre-
mediated recombination, as the DGwas normal in Cre expressing
mice with wild-type Grin1 alleles (Supplementary Figure S2).
Thus, ablation of NMDARs in CA1 and DG causes selective
degeneration of granule cells in the dorsal DG.
Neuronal Degeneration in Grin1DGCA1
Mice Affects Mature DG Granule Cells
To corroborate that NMDAR deletion causes cell death of mature
DG granule cells, we compared the distribution of immature
doublecortin (DCX) expressing cells (Figure 2A) and of
degenerating cells visualized by active caspase-3 immunostaining
(Figure 2B) within the DG granule cell layer (Figure 2C).
If degeneration aﬀected primarily immature DG granule cells,
degenerating cells should be conﬁned to the innermost rim of
the DG granule cell layer that harbors DCX expressing neurons.
This, however, was not the case. Degenerating cells were found
throughout the entire DG granule cell layer (Figure 2D). We next
Frontiers in Molecular Neuroscience | www.frontiersin.org 3 January 2016 | Volume 8 | Article 87
Watanabe et al. DG Degeneration Following NDMAR Ablation
FIGURE 1 | GluN1 deletion causes age-dependent neurodegeneration in the dorsal dentate gyrus (DG). (A) DAPI staining illustrating a section of a dorsal
DG from a 6 months old control (Ctrl) mouse. (B) DAPI staining of a dorsal DG from a 6 months old Grin1DGCA1 mouse. Note the thinning of the dentate granule
cell layer. (C) DAPI staining illustrating a section of a dorsal DG from an 18 months old control mouse. (D) DAPI staining of a dorsal DG from an 18 months old
Grin1DGCA1 mouse. Note the thinning of the dentate granule cell layer following profound neurodegeneration. (E) DAPI staining illustrating a section of a dorsal CA1
from an 18 months old control mouse. (F) DAPI staining of a dorsal DG from an 18 months old Grin1DGCA1 mouse. There is no difference between the two
genotypes. (G) Representative image from the DG showing an apoptotic, i.e., caspase-3-positive, CB-positive neuron in a 6 months old Grin1DGCA1 mouse. The
section is counterstained with DAPI. (H) Quantitative evaluation of dorsal DG thickness in 6 and 18 months old control and Grin1DGCA1 mice. The thickness of the
DG was analyzed by two-factor ANOVA, followed by pairwise comparison test with p-value modification by Holm’s method, ∗∗∗p < 0.0005. The DG is thinner in
Grin1DGCA1 mice [F (1,16) = 662.39, p < 0.0005], and the difference increases with aging [F (1,16) = 59.92, p < 0.0005]. There is a significant interaction between
genotype and age [F (1,16) = 53.99, p < 0.005]. (I) Quantitative evaluation of CA1 thickness in the dorsal hippocampus in 6 and 18 months old control and
Grin1DGCA1 mice. There is no difference in the thickness of the CA1 layer (two-factor ANOVA, no significant effect of genotype [F (1,16) = 0.594], no significant
effect of age [F (1,16) = 2.793], and no significant interaction between age and genotype [F (1,16) = 0.168]. Scale bars, in (F), which applies to (A–E), and (G), 200
and 10 μm, respectively. Five and four mice for 6 months old control and Grin1DGCA1, and six and five mice for 18 months old control and Grin1DGCA1 were used,
respectively.
examined whether there was a correlation between the number
of immature and degenerating DG granule cells. Since the
number of immature DG granule cells decreases with age, both
populations would have to decrease in parallel, if degenerating
cells were primarily immature DG granule cells. However, while
the number of immature DG granule cells decreased with age
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FIGURE 2 | N-methyl-D-aspartate receptor (NMDAR) depletion in Grin1DGCA1 mice causes age-dependent degeneration of mature DG granule cells.
(A) DAPI stained section (blue) from a 6 months old Grin1DGCA1 mouse brain showing DCX-positive (abbreviated DCX+ in the figure) neurons (red) located in the
inner DG granule cell layer. (B) DAPI stained section (blue) from a 6 months old Grin1DGCA1 mouse with degenerating neurons (green) dispersed throughout the
layer. (C) Diagram indicating the parameters that were used to calculate the relative position of individual DG granule cells. (D) Histogram, density plot (curved line),
and boxplot (bottom) of the relative position of DCX-positive cells (pink) and degenerating cells (blue) showing the differential distribution within the DG granule cell
layer (significant difference in both Kolmogorov–Smirnov Tests and Mann–Whitney–Wilcoxon Test, ∗∗∗p < 0.0005). Whiskers extending from the boxes in the boxplot
indicate the maximum and minimum value within the 1.5-fold of the interquartile range from the higher (75th percentile) and the lower quartile (25th percentile). Dots
in the boxplot are outliers. This analysis comprised 405 DCX-positive cells and 173 degenerating cells. (E) The number of DCX-positive cells in the DG decreases
with age both in control and Grin1DGCA1 mice [two-factor ANOVA, F (1,16) = 30.090, p < 0.00005]. There is neither a significant difference between genotypes
[F (1,16) = 0.653], nor a significant interaction between age and genotype [F (1,16) = 0.423]. (F) The number of degenerating neurons in the DG is higher in
Grin1DGCA1 mice [two-factor ANOVA, F (1,16) = 85.593, p < 0.00005, followed by post hoc analysis with Holm’s p-value modification, ∗∗∗p < 0.0005]. There is
neither an effect of age [F (1,16) = 0.247, ns], nor a significant interaction between age and genotype [F (1,16) = 0.888]. (G) There is no correlation between the
number of degenerating and newborn neurons in the DG of Grin1DGCA1 mice (Spearman’s rank correlation coefficient test). The same animals were used as in
Figure 1. Scale bar in (B), 25 μm.
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both in control and Grin1DGCA1 mice (Figure 2E), the number
of degenerating cells was higher in Grin1DGCA1 mice than
in controls both at 6 and 18 months of age (Figure 2F).
Furthermore, in Grin1DGCA1 mice, there was no correlation
between the number of immature DG granule cells and the
number of degenerating cells, suggesting that degenerating cells
were not immature cells (Figure 2G). Together these results
indicate that degenerating DG granule cells are primarily mature
DG granule cells.
NMDAR Dependent Survival is a Cell
Type-Specific Property of Mature DG
Granule Cells
In Grin1DGCA1 mice, DG granule cell degeneration might be
a complex phenotype that results from changed interactions
between CA1 and DG network activities, and might reﬂect, at
least in part, altered output activity from CA1 neurons, in which
NMDARswere also deleted. To directly test whether the observed
degeneration of mature DG granule cells following GluN1
depletion is indicative of a speciﬁc DG granule cell vulnerability,
we investigated the eﬀect of NMDAR depletion in genetically
modiﬁed mice (Grin1DG), in which the manipulation was
restricted to the DG. Indeed, a reduction in the thickness of the
dentate granule cell layer with degenerating cells was seen also
in 6 months old Grin1DG mice (Figures 3A–D,G,H), indicating
that adult granule cells require NMDAR-mediated activity for
their survival.
Similarly to Grin1DGCA1 mice, also in Grin1DG mice
the number of immature DG granule cells was not reduced
(Figures 3E,F,I), suggesting that GluN1 depletion was restricted
to mature DG granule cells. Hence we determined Cre expression
in mature and immature DG granule cells, and found that
indeed, Cre expression was detected in CB-positive, but not
DCX-positive neurons both in Grin1DG (Figures 3J–O)
and in Grin1DGCA1 mice (data not shown). Accordingly,
GluN1 expression was present in immature DG granule cells
(Supplementary Figures S3A–D). Together, these data provide
evidence that GluN1 ablation was restricted to mature DG
granule cells.
We wondered whether DG granule cell degeneration
following NMDAR ablation was noticeable already at earlier
developmental stages, and thus investigated 2 months old
Grin1DG mice. Despite of the GluN1 ablation, the number of
immature and degenerating DG granule cells, and the overall
thickness of the granule cell layer were comparable between
control and mutant mice (Supplementary Figures S3E–I). It thus
appears that the phenotype of DG granule cell degeneration
following NMDAR ablation worsens in an age-dependent
fashion.
Next we examined whether the genetic manipulation altered
the number of stem cells in the DG of 6 months old
Grin1DG mice. The number of stem cells, i.e., GFAP/Sox2
positive cells, was not diﬀerent between the two genotypes.
The increased number of GFAP/Sox2/S100β positive cells in
Grin1DG mice (Supplementary Figure S4), reﬂects enhanced
proliferation of astrocytes as often reported in brain areas with
neurodegeneration. Hence NMDAR depletion in mature DG
granule cells does not aﬀect stem cell proliferation.
Survival of Mature DG Granule Cells
Requires GluN2B Expression
Finally, to examine the composition of the NMDARs involved
in the degeneration of DG granule cells, we investigated the
survival of mature DG granule cells in mice with either GluN2A
or GluN2B receptor ablation. To this end we took recourse
to 18 months old Grin2a−/− and Grin2bDGCA1 mice. In
Grin2a−/− mice, the overall appearance and thickness of the DG
granule cell layer was not diﬀerent from that in control mice
(Figures 4A,B,E). In contrast, the DG ofGrin2bDGCA1 mice was
reminiscent of the above-described phenotype in Grin1DGCA1
and Grin1DG mice (Figures 4C,D,F). These data demonstrate
that GluN2B-containing NMDARs support the survival of aged
dorsal DG granule cells.
DISCUSSION
Here we demonstrate that NMDAR ablation causes
neurodegeneration of the DG. This phenotype derives from
the demise of mature DG granule cells and not from altered
neurogenesis for the following reasons: First, enhanced caspase-3
expression and degenerating neurons were detected in the outer
DG granule cell layer in the mutant mice. Second, the number of
stem cells in the DG did not diﬀer between control and mutant
mice. Third, neurogenesis in the DG is known to decrease with
age. Thus, if NMDAR ablation aﬀected newborn cells, one would
expect a progressive age-dependent decline of degenerating
neurons. This, however, was not the case. Fourth, GluN1 was
depleted primarily in mature DG granule cells as evidenced
both by Cre expression and GluN1 immunohistochemistry
in Grin1DG mice. In addition, previous studies indicated
that in several mouse mutants with reduced adult or absent
adult neurogenesis the size or thickness of the DG granule cell
layer was not visibly altered (Ansorg et al., 2012; Ouchi et al.,
2013).
As evidenced in Grin1DGCA1 mice, neurodegeneration
following NMDAR ablation was region- and cell type-speciﬁc.
Thus, dorsal but not ventral DG granule cell or CA1 pyramidal
neurons were aﬀected. A similar phenotype as the one detected
in Grin1DGCA1 and Grin1DG mice was also reported in
two other animal models of neurodegeneration. Thus, in rats,
adrenalectomy causes degeneration of granule cells in the
dorsal DG. The ventral DG is much less aﬀected, and CA1
neurons or other hippocampal regions not at all (e.g., Sloviter
et al., 1993). The pro-survival eﬀect of corticosterone appears
to be mediated by mineralocorticoid receptors (Gass et al.,
2000). We do not think, however, that altered downstream
signaling in mice with NMDAR ablation in DG granule
cell involves signaling via mineralocorticoid receptors as
their expression was not aﬀected in our mutants (data not
shown).
Notably, transgenic mice overexpressing Gsk3β also exhibit
degeneration of granule cells preferentially in the dorsal DG
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FIGURE 3 | DG selective deletion of GluN1 in Grin1DG recapitulates the phenotype observed in Grin1DGCA1 mice. (A) DAPI stained section showing the
DG of a 6 months old control mouse. (B) DAPI stained section from a 6 months old Grin1DG mouse brain showing thinning of the DG. (C–F) Degenerating cells
[green in (C,D)] and DCX-positive cells [red in (E,F)] in the DG of a 6 months old control and Grin1DG mouse. (G) DG thickness is reduced in Grin1DG mice
(Welch’s t-test, ∗∗∗p < 0.0005). (H) The number of degenerating cells is increased in the DG of Grin1DG mice (Welch’s t-test, ∗∗p < 0.005). (I) The number of
DCX-positive immature cells is comparable between genotypes (Welch’s t-test). (J–O) In the DG of Grin1DG mice, Cre (red) is expressed in CB-positive [green in
(J–L)] mature neurons, but not in DCX-positive [green in (M–O)] immature neurons. Right panels (K,L,N,O) show a magnified view of the indicated area [white boxes
in (J,M)]. Scale bars in (B,F,M,O), 100, 20, 100, and 20 μm, respectively. Five and seven mice were used for control and Grin1DG , respectively.
(Fuster-Matanzo et al., 2011), and the alteration is accompanied
by activated astrocytes (e.g., Fuster-Matanzo et al., 2011).
Interestingly, Gsk3β is more active in the dorsal, whilst
Akt, an inhibitor of Gsk3β, is more active in the ventral
hippocampus (Fuster-Matanzo et al., 2011). Conversely, chronic
application of lithium, an inhibitor of Gsk3β, ameliorates
DG neurodegeneration induced by injection of amyloid-β
ﬁbrils (De Ferrari et al., 2003). Notably, there is evidence
that β-catenin, a substrate of Gsk3β, directly interacts with
the NMDAR (Al-Hallaq et al., 2007). Accordingly, GluN2B-
containing NMDARs suppress apoptosis induced by Gsk3β
overexpression in cultured neurons (Habas et al., 2006).
It was surprising that GluN2B, but not GluN2A, was
required for the survival of DG granule cells, as several
studies provided ample evidence that GluN2B-containing
receptors mediate excitotoxic neuronal cell death (reviewed
in Hardingham and Bading, 2010). There are nevertheless
reports proposing that under certain conditions GluN2B
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FIGURE 4 | Absence of GluN2B-, but not GluN2A-containing NMDARs causes age-associated neurodegeneration of granule cells in the dorsal DG.
(A) Nissl staining of the DG from an 18 months old control mouse. (B) Nissl staining of the DG from an 18 months old Grin2a− /− mouse. (C) Nissl staining of the DG
from an 18 months old control mouse. (D) Nissl staining of the DG from an 18 months old control mouse (Grin2bDGCA1). (E) Quantitative evaluation of the granule
cell layer thickness in the DG of control and Grin2a−/− mice (Student’s t-test, ns). (F) Quantitative evaluation of the granule cell layer thickness in the DG of control
and Grin2bDGCA1 mice (Welch’s t-test, ∗p < 0.05). Scale bar in (D), 200 μm. Four and three mice for control and Grin2a−/−, and three and three mice for control
and Grin2bDGCA1 were used, respectively.
activation provides also pro-survival signals (Habas et al.,
2006).
Our ﬁndings have implications for therapeutic approaches in
which chronic NMDAR antagonist treatment is envisaged. Thus,
NMDAR antagonists have been considered for treatment of many
neurological diseases, including cerebral ischemia, traumatic
brain injury, pain, Alzheimer’s disease, Huntington’s disease,
Parkinson’s disease, autism spectrum disorders, and depression
(reviewed in Paoletti et al., 2013). In some cases, treatment
appeared promising, at least in animal models (Paoletti et al.,
2013; Patrizi et al., 2015). In humans, the NMDAR antagonist
ketamine shows promising eﬀects in patients with neuropathic
pain and depression (reviewed in Niesters et al., 2014; Iadarola
et al., 2015). Surveillance of the literature, however, indicates
that in most studies the treatment was short, ranging from
1 day to few weeks. Importantly, ketamine, is also used for
recreational purposes, and the longest period of drug intake
exceeds 10 years (Liao et al., 2010). Chronic use of ketamine
has long-lasting devastating eﬀects on brain function, including
working memory and episodic memory deﬁcits (reviewed in
Morgan and Curran, 2012). Based on our results, we propose
that NMDAR antagonists, whilst potentially beneﬁcial for acute
treatment, bear the risk of causing DG degeneration following
chronic administration, which would contribute to the worsening
of cognitive functions, considering the crucial role of the DG
in memory processes. It is not clear, however, to which extent
the results that we obtained in mice following genetic receptor
ablation can be transferred to humans, and in particular whether
chronic NMDAR antagonist administration mimics the results
reported here. Finally, the results warrant further investigations
as to the downstream cellular signal cascade that eventually leads
to the region-speciﬁc cell death. It is tempting to propose a
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putative involvement of Gsk3β, but so far this hypothesis remains
speculative.
In summary, mature granule cells in the dorsal DG undergo
neurodegeneration following NMDARablation in agedmice. The
study provides evidence that caution must be exerted, especially
in aged patients, when long-term administration of NMDAR
antagonists is considered for therapeutic purposes. Identiﬁcation
of downstream pathways leading to neurodegeneration following
NMDAR ablation is warranted to eventually establish safe clinical
administration of NMDAR antagonists.
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